Skip to main content
. 2021 Mar 5;12:645446. doi: 10.3389/fimmu.2021.645446

Table 1.

Multiplex analysis of plasma.

No Analytea Day 0 median Day 0 (IQR) 6M median 6M (IQR) p-valueb
T cell response related
1 IFN-gamma 53 34.1–80.3 27 19.8–37.7 <0.0001
2 IL-18 116 30.5–187.6 51 18.5–104.3 <0.0001
3 CD40-Ligand 236 0–305 0 0–245 <0.0001
4 IP-10 240 109–375 67 24–148 <0.0001
5 MIG 968 707–1256 526 0–715.5 <0.0001
6 IL-16 1,637 1,107–1,840 1,119 743–1,610 <0.0001
7 IL-2R 25,084 15,178–40,542 7,953 4,746–13,525 <0.0001
8 TSLP 19 9.9–30.5 4 0–15 0.0006
9 I-TAC 314 0–735 0 0–326 0.0014
10 IL-2 32 11.5–91.1 18 11.5–106.7 0.19
11 IL-21 98 0–222.3 62 0–200.4 0.1
12 IL-17A 348 56–690 309 135.7–674.5 0.26
TNF superfamily related
13 TNF-RII 662 585–717 569 521–633 <0.0001
14 Tweak/TNFSF12 2,266 1,286–3,432 1,306 909–1,779 <0.0001
15 CD30 10,436 7,935–14,690 4,673 3,001–6,851 <0.0001
16 ENA-78(LIX) 859 407–1,973 603 323–1,425 0.004
17 APRIL 4,274 3,390–5,268 3,836 2,893–4,846 0.005
18 TNF-alpha 3 1.48–7.6 3 0.35–4.06 0.027
19 TRAIL 682 0–966 0 0–804 0.034
20 BAFF 49 0–96.7 0 0–126.6 0.427
Monocyte/macrophage related
21 MCP-2 25 12.9–38.9 11 6.6–15.7 <0.0001
22 MIP-1alpha 17 13–24 10 6.1–15 <0.0001
23 BLC 1,113 593.5–2,170 422 155.7–755.8 <0.0001
24 Eotaxin-3 72 0–102.8 0 0–36.7 0.0002
25 MDC/CCL22 4,374 1,529–10,229 1,515 446–4,264 0.0004
26 MIP-3alpha 26 9.7–55.9 10 2.7–35.1 0.0016
27 MIP-1beta 61 30.2–92.2 42 14.1–63.4 0.008
28 Eotaxin-2 6 0.9–20.3 2 0–12.3 0.071
29 Fractalkine 16 9.5–29.9 12 5.5–23 0.074
30 MCP-1 253 121.7–388.2 211 104.6–319.7 0.22
31 Eotaxin-1 14 7.3–38.7 11 5.6–47.9 0.78
Growth factors
32 VEGF-A 815 512.7–1,055 425 223.2–658.8 <0.0001
33 HGF 565 427.7–714 456 329–502.6 0.0005
34 MMP-1 1,879 1,065–4,429 1,649 764–2,731 0.049
35 SDF-1alpha 7,690 6,142–8,754 6,940 5,496–8,884 0.085
36 SCF 38 23.1–48.8 34 17.4–48.8 0.59
a

analyte concentrations expressed as median (IQR) pg/ml;

b

Wilcoxon matched pairs (n = 39).